My Companies
Notification
Account
Sudarshan Pharma allotted 9,000,000 equity shares to promoters following the conversion of 900,000 warrants, receiving ₹11.46 crore in balance payment. This increases the total paid-up capital to ₹24.97 crore. Post-allotment, promoter shareholding stands at 58.93%, with shares issued at an adjusted price of ₹16.983 each.
Sudarshan Pharma Approves 9.5% MedTherapy Biotechnology Stake Acquisition
Sudarshan Pharma Promoters Pledge 66.5 Lakh Shares Each To Satin Finserv
Sudarshan Pharma Industries Promoters Pledge 1.32 Crore Shares To Satin Finserv
Sudarshan Pharma Converts USD1.5 Million FCCBs Into 48.1 Lakh Shares
Sudarshan Pharma Creates 3.25% Promoter Pledge To Secure Company Loan